Reduxin is intended for appetite suppression for the purpose of attaining weight loss in the treatment of patients with obesity.
- Sibutramine hydrochloride monohydrate
- microcrystalline cellulose
- alimentary obesity with a body mass index (BMI) of 30 kg / m2 and more;
- nutritional obesity with a BMI of 27 kg / m2 or more in combination with other risk factors due to overweight (type 2 diabetes / non-insulin-independent / or dyslipoproteinemia).
Reduxine cannot be used by patients who had the cardiovascular diseases later. There are other contraindications, please consult with your doctor before use.
Package: 60 capsules, 10 mg